Palamar Joseph J, Le Austin
Department of Population Health, New York University Langone Medical Center, New York, NY, USA.
New York University College of Dentistry, New York, NY, USA.
Addict Res Theory. 2022;30(2):96-103. doi: 10.1080/16066359.2021.1940972. Epub 2021 Jun 24.
Research on the efficacy of ketamine in treating depression and 3,4-methylenedioxymethamphetamine (MDMA) in treating post-traumatic stress disorder have been widely covered by the media. Given recent widespread coverage of the efficacy of these drugs, it is important to determine whether such coverage influences prevalence of recreational use. While longitudinal studies would be most ideal for assessing this, to acquire preliminary data, we tested survey items assessing this potential phenomenon in a population known for high prevalence of use of these drugs.
Adults entering randomly selected nightclubs in New York City ( = 209) were surveyed about drug use. Questions were included to assess their perceived likelihood of recent media coverage about medical benefits associated with use of ketamine and MDMA affecting their own use.
Two-thirds (66.8%) of participants had ever used ecstasy/MDMA and 22.6% had ever used ketamine. The plurality of participants reported that media coverage about ketamine (46.1%) and MDMA (39.9%) did not affect their likelihood of using. 10.1% and 21.0% of participants reported increased likelihood of using ketamine and MDMA, respectively. 52.3% of those reporting past-month ketamine use and 6.1% of those reporting no lifetime use reported being more likely to use in response to media coverage about ketamine. 28.6% of those reporting past-month ecstasy use and 5.5% of those reporting no lifetime use reported being more likely to use in response to media coverage about MDMA.
Media coverage about the medical benefits of ketamine and MDMA might influence specific subsets of people to use.
氯胺酮治疗抑郁症以及3,4-亚甲基二氧甲基苯丙胺（摇头丸）治疗创伤后应激障碍的疗效研究已被媒体广泛报道。鉴于近期这些药物疗效的广泛报道，确定此类报道是否会影响娱乐性使用的流行率很重要。虽然纵向研究对于评估这一点最为理想，但为了获取初步数据，我们在以这些药物高使用率而闻名的人群中测试了评估这一潜在现象的调查项目。
对进入纽约市随机选择的夜总会的成年人（n = 209）进行药物使用情况调查。问题包括评估他们认为近期媒体对氯胺酮和摇头丸使用相关医疗益处的报道影响其自身使用的可能性。
三分之二（66.8%）的参与者曾使用过摇头丸，22.6%的参与者曾使用过氯胺酮。大多数参与者报告称，关于氯胺酮（46.1%）和摇头丸（39.9%）的媒体报道并未影响他们使用的可能性。10.1%和21.0%的参与者分别报告称使用氯胺酮和摇头丸的可能性增加。在报告过去一个月使用过氯胺酮的人中，52.3%以及在报告从未使用过氯胺酮的人中，6.1%报告称因媒体对氯胺酮的报道而更有可能使用。在报告过去一个月使用过摇头丸的人中，28.6%以及在报告从未使用过摇头丸的人中，5.5%报告称因媒体对摇头丸的报道而更有可能使用。
关于氯胺酮和摇头丸医疗益处的媒体报道可能会影响特定人群使用这些药物。
